The management of herpes simplex virus infection in pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 3, 1998, Pages 255-260

  Smith, J Richard ^a   Cowan, Frances M ^b   Munday, Patricia ^c  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c WATFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFECTIOUS COMPLICATION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; THIRD TRIMESTER PREGNANCY;

FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0031938751     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10083.x     Document Type: Article

References (38)

1. Brocklehurst P, Carney O, Ross E, Mindel A. The management of recurrent genital herpes in pregnancy: a postal survey of obstetric practice. Br J Obstet Gynaecol 1995; 101: 791–797.
2. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121: 847–854.
3. Govennent Statistical Service. Sexually transmitted diseases, Eng land 1995: new cases seen at NHS genito-urinary medicine clinics. Statistical Bulletin. Department of Health 1996; (14).
4. Ashley RL, Dalessio J, Dragavon J, Koutsky LA, Lee FK, Nahmias AJ, Stevens CE, Holmes KK, Corey L. Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay. Sex Trunsnr Di.r 1993; 20: 230–235.
5. Field PR, Ho DWT, Irving WL, Isaacs D, Cunningham AL. The reliability of serological tests for the diagnosis of genital herpes: a critique. Puthology 1993; 25: 175–179.
6. Johnson RE, Lee F, Hadgu A, McQuillan G, Aral SO, Keesling S, Nahrnias A. US genital herpes trends during the first decade of AIDS: prevalences increased in young whites and elevated in blacks [abstract]. Sex Trunsm Dis 1994; 21: S109.
7. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ 1994; 309: 1325–1329.
8. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat N, Lipinski CM, Wolner-Hanssen P, Corey L. The frequency of unrecognized type 2 herpes simplex virus infection among women. Sex Transni Dis 1990; 17: 90–94.
9. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual and racial correlates of apparent and inapparent Herpes simplex infections. J Infect Dis 1990; 162: 299–305.
10. Tookey PA, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinuf Epidemiol 1996; 10: 432–442.
11. Randolph AR, Washington E, Prober CG. Cesarean Delivery for women presenting with genital herpes lesions: efficacy. risks and Costs. JAMA 1993; 270: 77–82.
12. Chuang T. Neonatal herpes: incidence, prevention and consequences. Am JPrev Med 1988; 4: 47–53.
13. Stone KM, Brooks CA, Guinan ME, Alexander ER. National Surveillance for neonatal herpes simplex virus infection. Sex Transnt Dis 1989; 16: 152–156.
14. Forsgren M. Genital herpes simplex virus infection and incidence of neonatal disease in Sweden. Scand J Infect Dis 1994; 69: 3741.
15. Lissauer TJ, Shaw PJ, Underhill G. Neonatal herpes simplex pneumonia. Arch Dis Child 1984; 59: 668–670.
16. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RA, Watts H, Beny S, Herd M, Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509–515.
17. Brown ZA, Vontver LA, Benedetti J, Crithclow CW, Sells CJ, Berry S, Corey L. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987; 317: 1246–1251.
18. Arvin A, Hensleigh PA, Prober CG, Au DA, Kawa BS, Wittek AE, Palumbo PE, Paryani SG, Yeager AE. Failure of antepartum maternal cultures to predict the infants risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315: 796–800.
19. Brown ZA, Benedetti J, Ashley RL, Burchett S, Selke S, Berry S, Vontver LA, Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991: 324: 1247–1252.
20. Nahmias AJ, Josey WE, Naib ZN, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex infection. Atn J obstet Gynecol 1971; 110: 825–834.
21. Whitley R, Arvin A, Prober C et al., The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450–454.
22. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type I and type 2 neonatal herpes encephalitis in neurological outcome. Lancet 1988; 1:14.
23. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98: 958–972.
24. Vontver LA, Hickok DE, Brown Z, Reid L, Corey L. Recurrent herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982; 143: 75–84.
25. Grossman JHIII, Wallen WC, Sever JL. Management of genital herpes simplex virus infection during pregnancy. Obstet Gynerol 1981; 58: 1–4.
26. Prober CG, Sullcnder WM, Yasukawa LL, Au DA, Yeager AE, Arvin A. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes. N Engl J Med 1987; 316: 240–244.
27. Spangler JG, Kirk JK, Knudson MP. Uses and safety of acyclovir in pregnancy. J Fam Pract 1994; 38: 186–191.
28. Corey L, Benedetti J, Critchlow C et al. Treatment of primary first-episode genital herpes simplex virus infection with acyclovir: results of topical, intravenous and oral therapy. J Antimicroh Chemother 1983; 12: 79–88.
29. Mindel A, Adler MW, Sutherland S, Fiddian AP. Intravenous acyclovir treatment for primary genital herpes. Lancet 1982; 1: 697–700.
30. Acyclovir in Pregnancy Registry. International Interim Report: June 1 1984 through June 30 1989. Burroughs Wellcome Co, 1989.
31. Prober CG, Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson YJ, Whitley RJ, Arvin AM. The management of pregnancics complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992; 15: 1031–1038.
32. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988; 1: 926–928.
33. van Everdingen JJE, Peeters MF, ten Havc P. Neonatal herpes policy in the Netherlands: five years after a consensus conference. J Perinat Med 1993; 21: 371–375.
34. Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex [letter]. Lancet 1990; 336: 756.
35. Scott L, Jackson G, Sancez P et al. Prevention of Caesarean section for recurrcnt genital herpes simplex virus using acyclovir suppressive therapy [abstract]. 40th Annual Meeting of Society for Gynecologic Investigation; 1993; Vancouver, Canada.
36. Brocklchurst P, Kinghorn G, Carney O et al. A randoinised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 1998; 105: 275–280.
37. Haddad J, Langer B, Astruc D, Mcsser J, Lokiec F. Oral acyclovir and recurrent genital hcrpes during late pregnancy. Obstet Gynecol 1993; 82: 102–104.
38. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD. Acyclovir supprcssion to prevent Cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87: 69–73.